| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Trifluoperazine hydrochloride |
Is a |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine measurement |
Component |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental trifluoperazine poisoning |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Intentional trifluoperazine poisoning |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine overdose |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental trifluoperazine overdose |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional trifluoperazine overdose |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine overdose of undetermined intent |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine [antipsychotic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 5mg/5mL sugar free syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 10mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 15mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 1mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine [nausea] [see dh4..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochloride 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochlorid 2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochlorid 1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochloride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochlorid 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Oral form trifluoperazine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing trifluoperazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing trifluoperazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing tranylcypromine and trifluoperazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
2 |
| Trifluoperazine hydrochloride 2mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely trifluoperazine 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine 5mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Trifluoperazine poisoning (disorder) |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental trifluoperazine poisoning |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional trifluoperazine poisoning |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine adverse reaction |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to trifluoperazine (finding) |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Allergy to trifluoperazine (finding) |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Retinopathy caused by trifluoperazine |
Causative agent (attribute) |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely trifluoperazine 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 1 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely trifluoperazine 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 1 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 5 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine (as trifluoperazine hydrochloride) 200 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Tranylcypromine and trifluoperazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
2 |
| Product containing only trifluoperazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only trifluoperazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only trifluoperazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely trifluoperazine 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine 10 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Trifluoperazine 10 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
| Retinopathy caused by trifluoperazine |
Causative agent (attribute) |
True |
Trifluoperazine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]